LEXINGTON, Mass. & CLEVELAND--(BUSINESS WIRE)--Predictive Biosciences, a fully-integrated developer of novel molecular diagnostic cancer assays, and a subspecialty provider of anatomic pathology products and services nationwide, today announced the expansion of the Company’s leadership team with the appointment of two vice presidents: James R. Groves as vice president of lab operations and Mark J. Smith as vice president of information technology. The Company has also actively expanded its sales force to support growth within its existing commercial portfolio as well as the anticipated market launch of Predictive’s novel, non-invasive bladder cancer assay.
